Despite hitting a new high, the drugstore operator and pharmacy benefit manager's stock can continue to deliver healthy returns.
The world's largest engine maker had been on a tear before recently selling off. We spy a buying opportunity and expect shares to rise 20%.
The much ballyhooed electrical car maker announced quarterly results that exceeded estimates. However, investors wanted more.
Options traders can get their licks in as the formerly too-cool-for-school retailer takes it on the chin.
With the Fed on hold, bond prices seem to be going nowhere. Fixed-income writer Michael Aneiro sees opportunity in closed-end funds.
Academics and squash is an odd but curiously effective combo in America's under-served urban communities.
Mon, 04 Nov 2013 20:30:15 +0000Subscriber Content Read Preview
Discover may seem like an also-ran but investors should take a look at its bigger drivers -- smart lending and new banking products.
This feature tracks the performance of stocks Barron's has written about during 2013 -- both favorably and critically. For stocks featured in Barron's print magazine, prices are measured from the Friday before publication date to their current price. For stocks featured on Barrons.com, prices are measured from the trading day of publication date to their current price. This list includes U.S. stocks only, including ADRs, but not foreign stocks.